Zinc: indications in brain disorders

@article{Prakash2015ZincII,
  title={Zinc: indications in brain disorders},
  author={Atish Prakash and Kanchan Bharti and Abu Bakar Abdul Majeed},
  journal={Fundamental \& Clinical Pharmacology},
  year={2015},
  volume={29}
}
Zinc is the authoritative metal which is present in our body, and reactive zinc metal is crucial for neuronal signaling and is largely distributed within presynaptic vesicles. Zinc also plays an important role in synaptic function. At cellular level, zinc is a modulator of synaptic activity and neuronal plasticity in both development and adulthood. Different importers and transporters are involved in zinc homeostasis. ZnT‐3 is a main transporter involved in zinc homeostasis in the brain. It has… 
View on Wiley
ncbi.nlm.nih.gov
86 Citations
Highly Influential Citations
1
Background Citations
27

86 Citations

Metals and Mitochondria in Neurodegeneration

The Emerging Role for Zinc in Depression and Psychosis

Biochemistry and bench top evidence on putative molecular mechanisms of zinc as a psychiatric treatment and meta-analyses support the adjunctive use of zinc in major depression and a single study now supports zinc for psychotic symptoms are reviewed.

Endogenous antagonists of N‐methyl‐d‐aspartate receptor in schizophrenia

A systematic review of the neurobiology and the role of endogenous NMDA receptor antagonists in animal models of schizophrenia, and in patients, and highlights the pressing need to restore the NMda receptor functions for therapeutic benefits.

Zinc in schizophrenia: A meta-analysis.

Neuronal specific and non-specific responses to cadmium possibly involved in neurodegeneration: A toxicogenomics study in a human neuronal cell model.

Zinc as a Drug for Wilson’s Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury

The data correlating zinc deficiency with the insurgence and progression of Covid-19 with low zinc levels associated with severe disease states is presented and the relevance of zinc supplementation in aged people at risk for SARS-CoV-2 is underlined.

Serum levels of zinc and copper in epileptic children during long-term therapy with anticonvulsants

The authors recommended measuring serum Zn level in epileptic patients on long-term anticonvulsant therapy and to give them Zn supplements if proved to be Zn deficient, and presume that there is a need to conduct a large scale randomized prospective clinical trial in order to investigate the effect of combing oral Zn supplementation in epilepsy patients.

Stress hormone potentiates Zn(2+)-induced neurotoxicity via TRPM7 channel in dopaminergic neuron.

Protein Phosphatase 1 as a Potential Mediator of Aluminum Neurotoxicity

Serum zinc levels in acute psychiatric patients: A case series

...

References

SHOWING 1-10 OF 189 REFERENCES

Zinc homeostasis and neurodegenerative disorders

An overview of both clinical and experimental evidence that implicates a dysfunction in zinc homeostasis in the pathophysiology of depression, AD, and aging is provided.

Zinc: The brain's dark horse

A greater understanding of zinc's role in the central nervous system may allow for the development of therapeutic approaches where aberrant metal homeostasis is implicated in disease pathogenesis, and in fact its role may be underappreciated.

Brain, aging and neurodegeneration: Role of zinc ion availability

The role of zinc in the pathogenesis and treatment of central nervous system (CNS) diseases. Implications of zinc homeostasis for proper CNS function.

The appropriate zinc supplementation in brain diseases may help in the prevention as well as in the proper treatment of several brain dysfunctions.

Neuroimmunological aspects of the alterations in zinc homeostasis in the pathophysiology and treatment of depression

Repeated administration of antidepressants selectively increases and redistributes brain zinc in the hippocampus and zinc is an inhibitor of the glutama-te/NMDA receptor, in accordance with the glutamate hypothesis of antidepressant action.

Insight into zinc signaling from dietary zinc deficiency

Intracellular Zn2+ signaling in cognition

On the basis of the evidence of cognitive decline caused by the lack and/or the blockade of synaptic Zn2+ signaling, this article summarizes the involvement of intracellular Zn 2+ signaling in zincergic synapses in cognition and a hypothetical involvement of that in nonzincergic synapse.

Chemical Blocking of Zinc Ions in CNS Increases Neuronal Damage Following Traumatic Brain Injury (TBI) in Mice

This study revealed that chemical blocking of vesicular zinc ions, either by chelation with DEDTC or accumulation in zinc-selenium nanocrystals, worsened the effects on the aftermath of TBI in the WT mice by increasing the number of necrotic and apoptotic cells within the first 24 hours after TBI, when compared to those of chemically untreated WT mice.

Synaptically released zinc: Physiological functions and pathological effects

The physiological and pathological effects of the release of zinc from these zinc-containing synaptic terminals are reviewed and it is hypothesize that zinc signals may loosely mimic phosphate `signals' in the sense that signal zinc ions may commonly bind to proteins in a lasting manner with consequential changes in protein structure and function.

The Neurophysiology and Pathology of Brain Zinc

The most recent findings that link zinc to synaptic function as well as the injurious effects of zinc dyshomeostasis within the context of neuronal death associated with major human neurological disorders, including stroke, epilepsy, and Alzheimer's disease are reviewed.
...